08/12/2025 10:05 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/21/2025 11:03 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2025 11:36 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2025 1:47 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2025 5:15 AM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/18/2025 7:42 AM | Provectus Biopharmaceuticals (Filer)
| Form DEFA14A | |
06/18/2025 7:43 AM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2025 5:24 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/27/2025 3:32 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2025 1:24 PM | Provectus Biopharmaceuticals (Filer)
| Form 10-K/A | |
05/15/2025 8:09 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for PVCT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
05/08/2025 8:46 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2025 5:14 AM | Provectus Biopharmaceuticals (Filer)
| Form ARS | |
04/30/2025 10:38 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/21/2025 1:22 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2025 12:35 PM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/08/2025 2:13 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2025 4:06 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2025 6:20 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2025 7:37 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2025 10:47 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2025 3:26 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/19/2025 10:10 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2025 12:37 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2025 4:13 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2025 2:57 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2025 12:31 PM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2025 3:33 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2024 8:30 AM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2024 8:00 AM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2024 6:45 PM | Pershing Edward (Filed by) Provectus Biopharmaceuticals (Subject)
| Form SC 13D/A | |
12/02/2024 6:48 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/25/2024 4:12 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 7:00 AM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2024 11:31 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 6:58 PM | Bailey Webster (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 7:01 PM | Lacey John III (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 7:06 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 5:56 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 5:58 PM | Provectus Biopharmaceuticals (Issuer) Rodrigues Dominic (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 4:21 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Trump’s national nightmare is here (Ad) Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II.
They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes. Watch the National Emergency broadcast here |
08/30/2024 8:54 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/27/2024 10:15 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 2:06 PM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |